LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS
Letters of Intent Receipt Date(s): April 11, 2005
Application Receipt Date(s): May 11, 2005
The objective of this RFA is to establish the Leadership of three to six
HIV/AIDS Clinical Trials Networks to carry out the NIAID research agenda in
the following areas: (1) Vaccine Research and Development; (2)
Translational Research/Drug Development; (3) Optimization of Clinical
Management, Including Co-Morbidities; (4) Microbicides; (5) Prevention of
Mother-to-Child Transmission (MTCT) of HIV; and (6) Prevention of HIV
Infection. NIAID and collaborating ICs anticipate awarding $150 million in
FY2006 to fund the Leadership of approximately three to six HIV/AIDS
Clinical Trials Networks. Networks are expected to vary substantially in
size and scope of activities. For this reason, the amount of first-year
awards is expected to vary; however, the range of awards is anticipated to
be from $10 million to $20 million direct costs for the three Network
Leadership components combined.
This funding opportunity will use the U01 award mechanism(s). As an
applicant, you will be solely responsible for planning, directing, and
executing the proposed project.
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-05-001.html